These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35085515)

  • 21. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
    Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
    Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
    Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
    Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AA amyloidosis: basic knowledge, unmet needs and future treatments.
    Obici L; Merlini G
    Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic amyloidosis: practical diagnosis].
    Noël LH
    Nephrol Ther; 2010 Apr; 6(2):88-96. PubMed ID: 20097147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic inflammation and AA amyloidosis].
    Blank N; Schönland SO
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1835-8. PubMed ID: 24006165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.
    Dasari S; Amin MS; Kurtin PJ; Vrana JA; Theis JD; Grogg KL; Alexander MP; Nasr SH; Fervenza FC; Leung N; Sethi S
    Kidney Int; 2016 Sep; 90(3):658-64. PubMed ID: 27262366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and therapeutic aspects of AA amyloidosis.
    Hazenberg BP; van Rijswijk MH
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):661-90. PubMed ID: 7954868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
    Lobato L; Beirão I; Silva M; Fonseca I; Queirós J; Rocha G; Sarmento AM; Sousa A; Sequeiros J
    Amyloid; 2004 Mar; 11(1):27-37. PubMed ID: 15185496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and outcomes of renal amyloidosis in Hong Kong.
    Lin RCC; Yuen SK; Cheung SF; Tang HL; Fung SKS
    Nephrology (Carlton); 2022 Nov; 27(11):869-876. PubMed ID: 36054582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AA amyloidosis complicating the hereditary periodic fever syndromes.
    Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundance.
    Pinney JH; Lachmann HJ; Sattianayagam PT; Gibbs SD; Wechalekar AD; Venner CP; Whelan CJ; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Am J Transplant; 2013 Feb; 13(2):433-41. PubMed ID: 23167457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eprodisate for the treatment of renal disease in AA amyloidosis.
    Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Puéchal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M;
    N Engl J Med; 2007 Jun; 356(23):2349-60. PubMed ID: 17554116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialysis treatment in children with amyloidosis due to juvenile rheumatoid arthritis.
    Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
    Turk J Pediatr; 1996; 38(1):59-66. PubMed ID: 8819622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloidosis and the Kidney: An Update.
    Nader R; Angel-Korman A; Havasi A
    Semin Nephrol; 2022 Nov; 42(6):151343. PubMed ID: 37148782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical presentation of atypical amyloid.
    Holanda DG; Acharya VK; Dogan A; Racusen LC; Atta MG
    Nephrol Dial Transplant; 2011 Jan; 26(1):373-6. PubMed ID: 20940371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary amyloidosis in ankylosing spondylitis.
    Dönmez S; Pamuk ÖN; Pamuk GE; Aydoğdu E; Inman R
    Rheumatol Int; 2013 Jul; 33(7):1725-9. PubMed ID: 23283540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary, AA, Amyloidosis.
    Papa R; Lachmann HJ
    Rheum Dis Clin North Am; 2018 Nov; 44(4):585-603. PubMed ID: 30274625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.